NCT01660360View on ClinicalTrials.gov

Phase I Trial of Tanibirumab in Advanced or Metastatic Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions
Advanced CancerMetastatic Cancer
Interventions
BIOLOGICAL

Tanibirumab

Trial Locations (1)

135-230

Samsung Medical Center, Seoul

Sponsors

Lead Sponsor

PharmAbcine
All Listed Sponsors
lead

PharmAbcine

INDUSTRY

NCT01660360 - Phase I Trial of Tanibirumab in Advanced or Metastatic Cancer | Biotech Hunter | Biotech Hunter